Skip to main content
Immunology logoLink to Immunology
. 1985 Sep;56(1):113–118.

Serum IL-2 inhibitor in mice. I. Increase during infection.

R Lelchuk, J H Playfair
PMCID: PMC1453670  PMID: 3899918

Abstract

Serum from normal mice contains an inhibitor of interleukin-2 (IL-2) which probably interacts directly with IL-2. Athymic mice and normal mice kept under specific pathogen-free conditions do not show this activity, whereas mice infected with malaria parasites have increased serum levels of inhibitor. This IL-2 inhibitor may play an important part in regulating T-cell function.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cottrell B. J., Playfair J. H., De Souza B. J. Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol. 1978 Nov;34(2):147–158. [PMC free article] [PubMed] [Google Scholar]
  2. Gautam S. C., Hilfiker M. L., Battisto J. R. In vivo development of cytolytic T lymphocytes (CTL) to hapten-altered self: MIs-disparate cells facilitate the response by neutralizing IL 2 inhibitor. J Immunol. 1983 Feb;130(2):533–537. [PubMed] [Google Scholar]
  3. Hardt C., Röllinghoff M., Pfizenmaier K., Mosmann H., Wagner H. Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo. J Exp Med. 1981 Aug 1;154(2):262–274. doi: 10.1084/jem.154.2.262. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Harel-Bellan A., Joskowicz M., Fradelizi D., Eisen H. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc Natl Acad Sci U S A. 1983 Jun;80(11):3466–3469. doi: 10.1073/pnas.80.11.3466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Jayawardena A. N., Targett G. A., Leuchars E., Carter R. L., Doenhoff M. J., Davies A. J. T-cell activation in murine malaria. Nature. 1975 Nov 13;258(5531):149–151. doi: 10.1038/258149a0. [DOI] [PubMed] [Google Scholar]
  6. Lelchuk R., Rose G., Playfair J. H. Changes in the capacity of macrophages and T cells to produce interleukins during murine malaria infection. Cell Immunol. 1984 Apr 1;84(2):253–263. doi: 10.1016/0008-8749(84)90097-2. [DOI] [PubMed] [Google Scholar]
  7. Lelchuk R., Sprott V. M., Playfair J. H. Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol. 1981 Aug;45(2):433–438. [PMC free article] [PubMed] [Google Scholar]
  8. Male D., Lelchuk R., Curry S., Pryce G., Playfair J. H. Serum IL-2 inhibitor in mice. II. Molecular characteristics. Immunology. 1985 Sep;56(1):119–125. [PMC free article] [PubMed] [Google Scholar]
  9. Malkovsky M., Asherson G. L., Stockinger B., Watkins M. C. Nonspecific inhibitor released by T acceptor cells reduces the production of interleukin-2. Nature. 1982 Dec 16;300(5893):652–655. doi: 10.1038/300652a0. [DOI] [PubMed] [Google Scholar]
  10. Mehra V., Brennan P. J., Rada E., Convit J., Bloom B. R. Lymphocyte suppression in leprosy induced by unique M. leprae glycolipid. Nature. 1984 Mar 8;308(5955):194–196. doi: 10.1038/308194a0. [DOI] [PubMed] [Google Scholar]
  11. Nelson D. S., Shneider C. N. Effect of normal mouse serum on mouse lymphocyte transformation in vitro. Eur J Immunol. 1974 Feb;4(2):79–86. doi: 10.1002/eji.1830040205. [DOI] [PubMed] [Google Scholar]
  12. Osawa H., Diamantstein T. A rat monoclonal antibody that binds specifically to mouse T lymphoblasts and inhibits IL 2 receptor functions: a putative anti-IL 2 receptor antibody. J Immunol. 1984 May;132(5):2445–2450. [PubMed] [Google Scholar]
  13. Weidanz W. P. Malaria and alterations in immune reactivity. Br Med Bull. 1982 May;38(2):167–172. doi: 10.1093/oxfordjournals.bmb.a071754. [DOI] [PubMed] [Google Scholar]
  14. de Souza J. B., Playfair J. H. Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii. Clin Exp Immunol. 1983 Oct;54(1):110–116. [PMC free article] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES